Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years of age
There is some evidence to support the effectiveness of preventative zinc supplementation particularly, where the risk of zinc deficiency is high. However, more evidence on optimal intervention characteristics such as supplement dose is needed.
Zinc deficiency is responsible for significant morbidity and mortality rates associated with diarrhoea, malaria and pneumonia in children aged six months to 12 years. The aim of the review was to assess the effects of zinc supplementation for preventing mortality and morbidity, and for promoting growth, in children aged six months to 12 years of age.
Both sexes (for groups of both male and female persons), Camp Coordination and Camp Management (CCCM), Child health, Children, Conflict, Displaced population, Earthquake, Endocrine and metabolic conditions, Epidemic/Endemic, Health, Infections and infectious diseases (all), Malaria and protozoal infections, Neonates/infants, Non-communicable diseases (all), Nutrition, Population displacement, Respiratory conditions, Vaccine-preventable infections, Viral fevers/VHF, Zoonotic and other pathogens